Page last updated: 2024-10-28

ha14-1 and Glial Cell Tumors

ha14-1 has been researched along with Glial Cell Tumors in 2 studies

ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hetschko, H1
Voss, V1
Senft, C1
Seifert, V1
Prehn, JH1
Kögel, D1
Weyland, M1
Manero, F1
Paillard, A1
Grée, D1
Viault, G1
Jarnet, D1
Menei, P1
Juin, P1
Chourpa, I1
Benoit, JP1
Grée, R1
Garcion, E1

Other Studies

2 other studies available for ha14-1 and Glial Cell Tumors

ArticleYear
BH3 mimetics reactivate autophagic cell death in anoxia-resistant malignant glioma cells.
    Neoplasia (New York, N.Y.), 2008, Volume: 10, Issue:8

    Topics: bcl-2-Associated X Protein; bcl-X Protein; Benzamides; Benzopyrans; Biomimetic Materials; Caspases;

2008
Mitochondrial targeting by use of lipid nanocapsules loaded with SV30, an analogue of the small-molecule Bcl-2 inhibitor HA14-1.
    Journal of controlled release : official journal of the Controlled Release Society, 2011, Apr-10, Volume: 151, Issue:1

    Topics: Animals; Antineoplastic Agents; Benzopyrans; Caspase 3; Cell Line, Tumor; Glioma; Lipids; Mitochondr

2011